Clinical Trial

Assessment of OSA in Latin American and Response to Neuromod Therapy

Study acronym: Trans-Q DISE
Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to characterize the upper airway of Latin American subjects who have been diagnosed with moderate/severe obstructive sleep apnea (OSA) and assess response to a neuromodulation therapy to treat OSA.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-30.
Trial Details
NCT Number NCT06762873
Lead Sponsor Lunair Medical
Conditions Obstructive Sleep Apnea
Enrollment 50 participants
Start Date 2024-11-21
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-03